Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
23.74
+5.08 (27.22%)
At close: Nov 6, 2026, 4:00 PM EST
23.50
-0.24 (-1.01%)
After-hours: Nov 6, 2026, 7:30 PM EST
Fulgent Genetics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 330.28 | 322.67 | 283.47 | 289.21 | 618.97 | 992.58 | |
Revenue Growth | 4.67% | 13.83% | -1.99% | -53.27% | -37.64% | 135.37% |
Cost of Revenue | 218.58 | 191.8 | 176.26 | 184.76 | 252.07 | 215.53 |
Gross Profit | 111.7 | 130.88 | 107.22 | 104.46 | 366.9 | 777.05 |
Selling, General & Admin | 168.5 | 158.11 | 124.35 | 130.47 | 149.99 | 75.17 |
Research & Development | 56.54 | 53.91 | 48.82 | 41.44 | 28.91 | 24.22 |
Amortization of Goodwill & Intangibles | 9.15 | 8.03 | 7.97 | 7.85 | 6.5 | 1.71 |
Operating Expenses | 234.18 | 220.05 | 181.13 | 179.75 | 185.4 | 101.1 |
Operating Income | -122.48 | -89.17 | -73.92 | -75.3 | 181.5 | 675.95 |
Interest Expense | -0.1 | -0.08 | - | -0.49 | -1.01 | -0.18 |
Interest & Investment Income | 30.55 | 30.92 | 31.3 | 21.61 | 5.62 | 0.34 |
Other Non Operating Income (Expenses) | 0.05 | 0.15 | 0.73 | 0.32 | 0.89 | - |
EBT Excluding Unusual Items | -91.99 | -58.18 | -41.88 | -53.85 | 187 | 676.11 |
Merger & Restructuring Charges | -4.82 | -1.92 | - | - | -2.98 | - |
Impairment of Goodwill | - | - | - | -120.23 | - | - |
Gain (Loss) on Sale of Investments | 9.93 | - | - | - | - | 4.92 |
Asset Writedown | -12.1 | -9.93 | -10.07 | - | - | - |
Pretax Income | -98.99 | -70.03 | -51.96 | -174.09 | 184.03 | 681.03 |
Income Tax Expense | -7 | -8.39 | -8.14 | 1.15 | 42.1 | 174.8 |
Earnings From Continuing Operations | -91.98 | -61.63 | -43.82 | -175.24 | 141.92 | 506.24 |
Net Income to Company | -91.98 | -61.63 | -43.82 | -175.24 | 141.92 | 506.24 |
Minority Interest in Earnings | 1.06 | 1.12 | 1.11 | 7.41 | 1.48 | 1.13 |
Net Income | -90.93 | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 |
Net Income to Common | -90.93 | -60.51 | -42.71 | -167.83 | 143.4 | 507.36 |
Net Income Growth | - | - | - | - | -71.74% | 136.74% |
Shares Outstanding (Basic) | 29 | 31 | 30 | 30 | 30 | 29 |
Shares Outstanding (Diluted) | 29 | 31 | 30 | 30 | 31 | 31 |
Shares Change | -4.30% | 1.79% | 1.51% | -3.81% | -0.04% | 28.77% |
EPS (Basic) | -3.10 | -1.97 | -1.41 | -5.63 | 4.76 | 17.25 |
EPS (Diluted) | -3.10 | -1.97 | -1.41 | -5.63 | 4.63 | 16.38 |
EPS Growth | - | - | - | - | -71.73% | 83.84% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -1.4 | -124.21 | -19.26 | 4.8 | 234.75 | 514.77 |
Free Cash Flow Per Share | -0.05 | -4.04 | -0.64 | 0.16 | 7.58 | 16.62 |
Gross Margin | 33.82% | 40.56% | 37.82% | 36.12% | 59.28% | 78.29% |
Operating Margin | -37.09% | -27.64% | -26.08% | -26.03% | 29.32% | 68.10% |
Profit Margin | -27.53% | -18.75% | -15.07% | -58.03% | 23.17% | 51.12% |
Free Cash Flow Margin | -0.42% | -38.50% | -6.79% | 1.66% | 37.92% | 51.86% |
EBITDA | -95.88 | -65.05 | -48.99 | -49.15 | 214.16 | 686.96 |
EBITDA Margin | -29.03% | -20.16% | -17.28% | -16.99% | 34.60% | 69.21% |
D&A For EBITDA | 26.6 | 24.12 | 24.93 | 26.14 | 32.66 | 11 |
EBIT | -122.48 | -89.17 | -73.92 | -75.3 | 181.5 | 675.95 |
EBIT Margin | -37.09% | -27.63% | -26.08% | -26.03% | 29.32% | 68.10% |
Effective Tax Rate | - | - | - | - | 22.88% | 25.67% |